SCHEMBL8304286

SCHEMBL8304286

COc1ccc(C(=O)NC2Cc3ccccc3C2=O)c(OC)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 1/20 0.49
WDR77 Q9BQA1 1/20 0.49
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
RAB9A P51151 3/20 0.47
ALDH1A1 P00352 1/20 0.47
GAA P10253 1/20 0.47
PKM P14618 1/20 0.47
HPGD P15428 1/20 0.47
HTT P42858 1/20 0.47
NPC1 O15118 1/20 0.47
NAMPT P43490 1/20 0.47
PDE4A P27815 1/20 0.47
PDE4B Q07343 1/20 0.47
PDE4C Q08493 1/20 0.47
PDE4D Q08499 1/20 0.47
PDE3B Q13370 1/20 0.47
PDE3A Q14432 1/20 0.47
TSHR P16473 1/20 0.46
TP53 P04637 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8304193 0.75 PRMT5 (0.49) PRMT5WDR77MEN1KMT2ARAB9A
SCHEMBL8308858 0.75 PRMT5 (0.49) PRMT5WDR77MEN1KMT2ARAB9A
SCHEMBL10947764 0.75 ACHE (0.49) MEN1KMT2ARAB9AALDH1A1PKM
SCHEMBL10947753 0.75 ACHE (0.49) MEN1KMT2ARAB9AALDH1A1PKM
SCHEMBL8765833 0.73 ACHE (0.58) GAALMNA
SCHEMBL626213 0.73 ACHE (0.58) GAALMNA
SCHEMBL8304284 0.73 SMN1; SMN2 (0.52) MEN1KMT2ARAB9AALDH1A1GAA
Ethylene SCHEMBL9316053 0.72 ACHE (0.46) MEN1KMT2ARAB9AALDH1A1PKM
Ethylene SCHEMBL8765917 0.71 ACHE (0.56) GAALMNA
SCHEMBL11239859 0.70 ALDH1A1 (0.70) PRMT5WDR77MEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0758312-B1 SUBSTITUTED FUSED AND BRIDGED BICYCLIC COMPOUNDS AS THERAPEUTIC AGENTS LILLY CO ELI (US) 1999-12-22 EP disclosed
EP-0758312-A4 SUBSTITUTED FUSED AND BRIDGED BICYCLIC COMPOUNDS AS THERAPEUTIC AGENTS LILLY CO ELI (US) 1997-09-10 EP disclosed
EP-0758312-A1 SUBSTITUTED FUSED AND BRIDGED BICYCLIC COMPOUNDS AS THERAPEUTIC AGENTS ELI LILLY AND COMPANY (US) 1997-02-19 EP disclosed
US-5583221-A ANTIINFLAMMATORY AGENTS, CARDIOVASCULAR DISORDERS, VIRICIDES, FUNGICIDES ELI LILLY AND COMPANY (US) 1996-12-10 US disclosed
WO-1995030640-A1 SUBSTITUTED FUSED AND BRIDGED BICYCLIC COMPOUNDS AS THERAPEUTIC AGENTS ELI LILLY AND COMPANY (US) 1995-11-16 WO disclosed